no code implementations • 29 Jan 2024 • Hadar Hezi, Matan Gelber, Alexander Balabanov, Yosef E. Maruvka, Moti Freiman
Treatment approaches for colorectal cancer (CRC) are highly dependent on the molecular subtype, as immunotherapy has shown efficacy in cases with microsatellite instability (MSI) but is ineffective for the microsatellite stable (MSS) subtype.